triazoles has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcott, J; Bertrand, HC; Callard, R; Castillo-Quan, JI; Cochemé, HM; Gatliff, J; Gomez Perez-Nievas, B; Ivanov, DK; Kerr, F; Khericha, M; Martinez, P; Noble, W; Partridge, L; Snoeren, I; Sofola-Adesakin, O; Thornton, J; Wells, G | 1 |
1 other study(ies) available for triazoles and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
| Article | Year |
|---|---|
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Gene Expression Profiling; Glycogen Synthase Kinase 3; Humans; Kelch-Like ECH-Associated Protein 1; Lithium Chloride; Longevity; Mice; Microscopy, Confocal; Neurons; NF-E2-Related Factor 2; Oleanolic Acid; Peptide Fragments; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Thiadiazoles; Triazoles | 2017 |